EFFECTS OF THE STAT3 INHIBITORS ON SENESCENT TUMOUR CELLS

被引：0
|
作者：
Sapega, O. [1 ]
Mikyskova, R. [1 ]
Musilek, K. [2 ]
Bieblova, J. [1 ]
Hodny, Z. [3 ]
Reinis, M. [1 ]
机构：
[1] ASCR, Inst Mol Genet, Lab Immunol & Tumour Models, Vvi, Prague, Czech Republic
[2] Univ Hradec Kralove, Dept Chem, Fac Sci, Hradec Kralove, Czech Republic
[3] ASCR, Inst Mol Genet, Dept Genome Integr, Vvi, Prague, Czech Republic
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-ITOC7.29
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01.16
引用
收藏
页码：A16 / A16
页数：1
相关论文
共 50 条
  • [21] STAT3 and its targeting inhibitors in osteosarcoma
    Liu, Yun
    Liao, Shijie
    Bennett, Samuel
    Tang, Haijun
    Song, Dezhi
    Wood, David
    Zhan, Xinli
    Xu, Jiake
    CELL PROLIFERATION, 2021, 54 (02)
  • [22] A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment
    Kadye, Rose
    Stoffels, Mihlali
    Fanucci, Sidne
    Mbanxa, Siso
    Prinsloo, Earl
    CELLS, 2020, 9 (04)
  • [23] Tetrapodal Stat3 inhibitors offer potent disruption of Stat3 in vitro and in whole cell assays
    Page, Brent D. G.
    Schimmer, Aaron
    Turkson, James
    Gunning, Patrick T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [24] Combination of ERK2 and STAT3 Inhibitors Promotes Anticancer Effects on Acute Lymphoblastic Leukemia Cells
    Jasek-Gajda, Ewa
    Jurkowska, Halina
    Jasinska, Malgorzata
    Litwin, Jan A.
    Lis, Grzegorz J.
    CANCER GENOMICS & PROTEOMICS, 2020, 17 (05) : 517 - 527
  • [25] STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction
    Demaria, Marco
    Giorgi, Carlotta
    Lebiedzinska, Magdalena
    Esposito, Giovanna
    D'Angeli, Luca
    Bartoli, Antonietta
    Gough, Daniel J.
    Turkson, James
    Levy, David E.
    Watson, Christine J.
    Wieckowski, Mariusz R.
    Provero, Paolo
    Pinton, Paolo
    Poli, Valeria
    AGING-US, 2010, 2 (11): : 823 - 842
  • [26] A stat3-mediated metabolic switch is involved in tumour transformation and stat3 addiction
    Demaria, M.
    Giorgi, C.
    Miano, V.
    Misale, S.
    Suski, J. M.
    Esposito, G.
    Provero, P.
    Wieckowski, M. R.
    Pinton, P.
    Poli, V.
    FEBS JOURNAL, 2011, 278 : 229 - 229
  • [27] Tumor immunology - STAT3 - a potential target for tumour immunotherapy
    Buckland, J
    NATURE REVIEWS IMMUNOLOGY, 2004, 4 (02) : 82 - 83
  • [28] The pulmonary effects of STAT3 deficiency
    Gilje, Elizabeth A.
    Abbott, Jordan K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 152 (02) : 368 - 370
  • [29] The development of peptide-based inhibitors of Stat3α
    Ren, Zhiyong
    Coleman, David R.
    Cabell, Larry A.
    McMurray, John S.
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 550 - 552
  • [30] Novel peptidomimetic inhibitors of Stat3 signaling and oncogenesis
    Turkson, J
    Kim, JS
    Zhang, S
    Yuan, J
    Huang, M
    Vultur, AM
    Raptis, L
    Sebti, S
    Hamilton, AD
    Jove, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S98 - S98
12345